24022270Havrdova E, Giovannoni G, Stefoski D, Forster S, Umans K, Mehta L, Greenberg S, Elkins JMultiple sclerosis (Houndmills, Basingstoke, England)Antibodies, Monoclonal, Humanized; Immunoglobulin G; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-RemittingAdolescent; Adult; Daclizumab; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Young AdultDisease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study. Mult Scler. 2014 Apr; 20(4):464-70.Mult Scler2013-09-10T00:00:002013Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD020529Disorders4240.975824Multiple Sclerosis, Relapsing-RemittingD004311Procedures1165030.892567Double-Blind MethodD007166Chemicals & Drugs571320.911164Immunosuppressive AgentsD018450Physiology1907870.790832Disease ProgressionD016896Concepts & Ideas36434750.519213Treatment OutcomeD000293Living Beings36322740.634821AdolescentDusanStefoskiDusan Stefoski349679Stefoski, DusanAssociate Professor5Associate ProfessorD061067Chemicals & Drugs411130.922308Antibodies, Monoclonal, HumanizedD008875Concepts & IdeasLiving Beings48398170.373681Middle AgedD055815Living Beings36919330.632314Young AdultAuthorship 106823D000328Living Beings51685930.393483AdultD008297Physiology564156270.299065Male0.1203560.1203561authors10.2514has subject areaD005260Physiology579162020.293532FemaleD007074Chemicals & Drugs471290.937414Immunoglobulin GNeurological SciencesRush University, Rush Medical Collegetrue1Associate ProfessorAssociate ProfessorD006801Living Beings643293340.211949Humans